Skip to main content
. 2021 Jan 31;54(3):e12979. doi: 10.1111/cpr.12979

FIGURE 3.

FIGURE 3

Distribution of estimated IC50 values of five chemotherapy drugs among the three immune‐specific subtypes. CAFs‐immune subtype was predicted to be resistant to all five drugs, while the activated‐immune subtype was sensitive to at least three drugs. Differences in estimated IC50 among three immune‐specific subtypes were evaluated by the Kruskal‐Wallis test. Pairwise comparisons were assessed by two‐sample Mann‐Whitney U test